Merck, Sandoz Resolve Patent Suit Over Cancidas
A New Jersey federal judge on Wednesday dismissed one of two patent lawsuits over Sandoz Inc.'s plans for a generic version of Merck & Co. Inc.'s anti-fungal medication Cancidas....To view the full article, register now.
Already a subscriber? Click here to view full article